According to the requirements of the contract, Langshan Pharmaceutical will be officially put into production within two months, that is, before eleven.

That is, since the third month of October, Rainbow has Xuetong's 30% profit sharing fund return, so that Rainbow sees hope.

However, what Lu Huan didn't expect was that two of the irreplaceable raw materials in Xuetong's traditional Chinese medicine raw materials were out of stock on the market.

There are only small quantities of sales, no large quantities, and the production area is also booked in advance.

The market will not solve the problem of out-of-stock for at least a year.

If there is a large need, you can only wait for the harvest of the next year, and you have to book in advance.

Two months is urgent, if the raw materials can't be solved, this new product is equivalent to buying in vain.

"No, we have to find a way to solve the API problem."

Lu Huan knew that the sales of scavengers were so hot, there must be sufficient raw materials.

The out-of-stock of two APIs on the market must be related to them.

It seems that there is a contradiction between Weiya Pharmaceutical and Rainbow.

She communicated the situation with Rainbow in a timely manner, saying that Rainbow had concealed the raw material problem and asked to change the contract, and the production date would be postponed until the raw material problem was resolved.

When Su Lie received Lu Huan's call, he also felt helpless, so he agreed to Lu Huan's request, but he still hoped that Langshan Pharmaceutical could seize the time to put into production.

Lu Huan was also very unhappy and said: "Langshan has spent so much money, don't you want to make money as soon as possible?" ”

Su Lie was speechless.

Just when Lu Huan was worried, Ling Nan got the information that Langshan Pharmaceutical had purchased the Rainbow production line and Xuetong capsules.

It is realized that the shortage of APIs in the market will be an inevitable problem affecting the production of Langshan Pharmaceutical.

They will definitely find out the reason for the shortage of APIs, and they will definitely find out that it is related to Weiya Pharmaceutical.

To do this, he contacted Oudan.

If someone from Langshan Pharmaceutical wants to negotiate the purchase of APIs, they can negotiate and sell the surplus two APIs, and the price can be twice as low as the current market price.

But it doesn't matter if you can drag it out, and if you can't.

In fact, in order to control the market, the two APIs monopolized by Oudan can't be eaten at all, and they have been backlogged in the inventory.

But the cost has long been earned.

The purpose of this one-month delay is not to deal with Langshan Pharmaceutical, but to indirectly put pressure on Rainbow and speed up its bankruptcy.

Sure enough, not long after Ou Dan communicated with Ling Nan, someone contacted the company, saying that someone from Langshan Pharmaceutical wanted to visit Mr. Ou.

Lu Huan personally went out and met Ou Dan at Weiya Pharmaceutical Investment Company.

The two strong women are naturally unconvinced when they meet, but they still have to show mutual politeness and self-cultivation on the surface.

In business, when it comes to business issues, both of them naturally stand on the side of their own company's interests, which no one will give into.

After greeting for a while, Lu Huan naturally discussed with Ou Dan in a deliberative tone and asked if he could sell them some of the APIs.

"Since I have a good exchange with Mr. Lu, it means that we are still destined. To be honest, the prices of these two APIs in the market have been rising, and we thought that there must be a manipulator behind them, but it is difficult to investigate. “

"So, I bought several batches at a high price. It's just that I bought it earlier, and I still have some inventory, which can be sold to Mr. Lu. The price can also be negotiated. Details can be arranged to talk in the next few days. ”

Ou Dan smiled slightly. She knew that even if she said this, she would not be able to hide Lu Huan's shrewdness as a businessman, but both of them knew it.

Ou Dan felt that the reason why Lu Huan contacted Weiya to buy these two APIs must have guessed that there might be a contradiction between Weiya and Tianhong, and even controlled these two drugs.

Therefore, in the negotiation just now, Ou Dan deliberately emphasized that "the price is high, and someone is manipulating" in order to inadvertently get rid of suspicion, and the subtext is to tell Lu Huan not to think that we control the source of goods, but in fact, our goods are also purchased at a high price, and there are not many, and only a part of them can be supplied to you.

"Okay, doing business with Mr. Ou is refreshing. I will send someone to discuss the details in detail, and today I will invite Mr. Ou to appreciate his face. ”

Lu Huan stood up as he spoke, and walked out under the guidance of the secretary.

.....

The next day, the negotiation began, and soon the price and quantity were negotiated, and Ou Dan did not agree to the quantity proposed by the other party, but only sold about 20% to them according to the quantity proposed by the other party, and said that he could only sell these, because the production of Weiya Pharmaceutical also needed it.

Weiya Pharmaceutical has doubled the market price, and on the grounds that the processing sites are not together, the two drugs can only be supplied separately, and there may be a buffer in time, and the supply can only be guaranteed within one month.

The conditions are not harsh and reasonable.

In the end, Langshan also agreed to this plan.

Lu Huan knew that there was a problem here, but she didn't care about Tianhong's thoughts.

After all, there is no contradiction between Langshan Pharmaceutical and Weiya Pharmaceutical, as long as it can be put into production as soon as possible.

There is no problem with delaying it for a month, which is thousands of times better than losing money without APIs.

Weiya Pharmaceutical also sees the mentality of the other party, and the total quantity of supply they control will not exceed the level of Langshan Pharmaceutical beyond the cost recovery.

Then Langshan communicated with Rainbow Company.

Langshan said that due to the shortage of APIs in the market, the problem cannot be solved for the time being, and the production may continue to be appropriately postponed according to the actual situation.

Rainbow was well aware of this factor and had no way to raise objections, and the two sides then supplemented the memorandum.

.....

The high-level of Rainbow fell into sorrow again because of the unexpected sudden change.

The postponement of two to three months is exactly at the end of the year, and the 30% profit that should be earned is temporarily in vain.

The patent fee of 20 million is also far away.

The key is that the bank loan cannot be repaid, and the interest repayment will be stretched.

They knew that there was a shortage of APIs in the market, and thought that it was a conspiracy against Rainbow Company, so they did not disclose this information to Langshan Pharmaceutical, who would have thought that Langshan Pharmaceutical would not be able to solve the shortage of APIs for the time being.

This is equivalent to although the production line is sold, the cooperation can not be put into production, and the rainbow company is undoubtedly its own shabu.

It can only speed up the production of traditional products and maintain employee expenses, and the personal investment of shareholders can only be deferred indefinitely.

And when necessary, shareholders would rather mortgage their family property to borrow money from banks than bankrupt the company.

Otherwise, personal property will not be kept.

In the early days of reform and opening up, many enterprise executives still did not understand the market, and they still followed the old routines of enterprise management.

The implementation of the internal shareholding system only understands the concept that everyone can share profits, and there is no reliable idea of how to operate well and how to better achieve profitability.

The relationship between products and markets is incomprehensible, and the sequelae of the planned economy have been deeply ingrained in their minds.

It even melted into their blood.

When there is a real crisis in the enterprise, we will know that it is too late.

The old shareholders were anxious, and all kinds of bad ideas emerged one after another, and they became a pot of porridge.

For the top management of Texhong, this is not the most worrying.

The most worrying thing is that when you are desperate, there is always a little hope.

And hope is always on the move.